Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/37303
Title: Elevation of tumour marker CA-125 in serum & body fluids: interpret with caution
Authors: Hussain, Syed Fayyaz
Camilleri, P.
First Published: Jan-2007
Publisher: Medknow Publications for Indian Council of Medical Research (ICMR)
Citation: Indian Journal of Medical Research 125, January 2007, pp 10-12
Abstract: First paragraph: The cancer antigen (CA) -125 is a high molecular mass glycoprotein produced both by ovarian cancer cells as also by normal cells of tissues derived from coelomic epithelium. Serum CA-125 levels are used as a marker of tumour activity in patients known to have ovarian carcinoma1 and commercial tests for serum CA-125 have been available since 1983. In women with histologically proven ovarian carcinoma, levels of serum CA-125 are elevated >35 U/ml in more than 80 per cent of cases. Levels are also measured after debulking surgery and during chemotherapy.
ISSN: 0971-5916
Links: http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2007;volume=125;issue=1;spage=10;epage=12;aulast=Hussain;type=0
http://hdl.handle.net/2381/37303
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Creative Commons Attribution Non-Commercial Share Alike License
Appears in Collections:Published Articles, College of Medicine, Biological Sciences and Psychology

Files in This Item:
File Description SizeFormat 
IndianJMedRes125110-2473217_065212.pdfPublisher version51.82 kBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.